VICTORIA CORREA: Open Payments
NPI 1508456716 · DOYLESTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$934 in 49 payments from 18 companies in 2025. Trend: 2023 $855 · 2024 $1,002 · 2025 $934
Food & beverage: $876Education: $59
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $139 |
| Regeneron Healthcare Solutions, Inc. | 5 | $124 |
| Novo Nordisk Inc | 7 | $117 |
| GENZYME CORPORATION | 5 | $107 |
| Astellas Pharma US Inc | 3 | $59 |
| Novartis Pharmaceuticals Corporation | 3 | $49 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $43 |
| Genentech USA, Inc. | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
Products named: DUPIXENT, AIRSUPRA, Ozempic, Veozah, AYVAKIT, TRELEGY ELLIPTA, NEFFY, Xolair.
Industry payments across PA — which companies pay providers there.
